Gilead Sciences Inc (NYSE:GILD) over-valued by 21%
Website | https://www.gilead.com/ |
Sector | Healthcare |
Industry | Drug Manufacturers General |
Fiscal Year End | Dec 31, 2021 |
Market Cap | $85,911,330,816 |
Beta | 0.39893 |
Average Volume | $7,741,875 |
Last Dividend | 2.75% |
Price on Nov 2, 2022 | $79.46 |
Autochartist™ Valuation | $62.96 |
Conclusion |
21% over-valued |
Download Report |